Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2025-08-14 00:00:00 ET · period of report 2025-08-12 · accession 0001674236-25-000010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-08-14 | 2025-08-12 | ANIP | CAREY STEPHEN P. | SVP, CFO | M - OptEx | $46.49 | +50.0K | 230.9K | +28% | +$2.32M |
| D | 2025-08-14 | 2025-08-12 | ANIP | CAREY STEPHEN P. | SVP, CFO | S - Sale+OE | $86.07 | -50.0K | 180.9K | -22% | -$4.30M |
| D | 2025-08-14 | 2025-08-12 | ANIP | CAREY STEPHEN P. | SVP, CFO | M - OptEx | $46.49 | -50.0K | 0 | -100% | -$2.32M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-12 | M | A | 50,000 | $46.49 | 230,863 | D | — | — | |
| 2 | Common | Common Stock | 2025-08-12 | S | D | 50,000 | $86.07 | 180,863 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2025-08-12 | M | D | 50,000 | $46.49 | 0 | D | $46.49 · — to 2026-05-05 | 50,000 Common Stock | (F1) 25% of the total options vested on each of May 6, 2017, May 6, 2018, May 6, 2019, and May 6, 2020. |